Raw Material Optimization to Bend the Biopharmaceutical Cost Curve
Raw materials sourced from sole third-party suppliers have been identified as one of the key risks to Amgen’s operation. This project aims to reduce raw material costs through sourcing alternative materials and optimizing material consumption. To systematically evaluate alternative material supp...
| Autor Principal: | |
|---|---|
| Outros autores: | |
| Formato: | Thesis |
| Publicado: |
Massachusetts Institute of Technology
2022
|
| Acceso en liña: | https://hdl.handle.net/1721.1/139545 |